Industry in brief | Reckitt Benckiser, Cefaly, BioGaia

13 October 2020 - Deborah Wilkes


Reckitt Benckiser (RB) has made a further investment in Your.MD, Cefaly Technology’s migraine treatment device is now available OTC in the US, and BioGaia has issued a sales warning.

Click tags below for more information on topics:

RB BioGaia

Annual Subscription Holder?

Sign in to continue reading.

Sign In

Back to Industry News

Share this page: